Cancer

A recent Mayo Clinic study shows that cancer practices can integrate telehealth without duplicative care, allowing for a more streamlined healthcare experience for patients and their caregivers.

Mayo Clinic researchers describe a previously unknown type of T cells that can survive harsh cancer therapies. The finding opens doors to studying new immunotherapy approaches for patients who have run out of treatment options.

Mayo Clinic researchers identified a cell-signaling protein that appears to drive pancreatic cancer cell growth that could be a potential therapeutic target.

In a study led by Mayo Clinic, researchers found invasive brain tumor margins of high-grade glioma with distinct genetic and molecular alterations that are detectable on clinical imaging with MRI and point to cancer recurrence. The findings suggest insights into improvements in diagnosis and potential treatments that could modify the course of the disease.

Mayo Clinic researchers created an ultrasound tool combined with artificial intelligence to improve cancer diagnosis and patient care.

A new type of CAR-T cell therapy is targeted to B-cell blood cancers that have returned and no longer respond to other treatments.

Mayo Clinic research is filling critical gaps in our understanding of breast cancer genetics to improve diagnosis and treatment.

Mayo Clinic's history of research into giant cell arteritis, an autoimmune disease, has led to recent discoveries that may result in new treatments.

Treatment options are improving outcomes for patients with pancreatic cancer. A new study shows that most report an excellent quality of life after surgery.

A Wisconsin man with chronic lymphocytic leukemia was out of therapeutic options. CAR-T cell therapy and a clinical trial put his disease in remission and gave him new hope for the future.